These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 16142707
21. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N, Rossi F, Bartoli M, Martini A, Ravelli A. Arthritis Rheum; 2005 Jul; 52(7):2092-102. PubMed ID: 15986372 [Abstract] [Full Text] [Related]
22. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? Kapral T, Dernoschnig F, Machold KP, Stamm T, Schoels M, Smolen JS, Aletaha D. Arthritis Res Ther; 2007 Jul; 9(4):R72. PubMed ID: 17662115 [Abstract] [Full Text] [Related]
23. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC, REFLEX Trial Group. Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627 [Abstract] [Full Text] [Related]
25. Assessment of disease activity in juvenile idiopathic arthritis. The number and the size of joints matter. Berntson L, Wernroth L, Fasth A, Aalto K, Herlin T, Nielsen S, Nordal E, Rygg M, Zak M. J Rheumatol; 2007 Oct; 34(10):2106-11. PubMed ID: 17896798 [Abstract] [Full Text] [Related]
27. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease. Ringold S, Bittner R, Neogi T, Wallace CA, Singer NG. Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1095-102. PubMed ID: 20506561 [Abstract] [Full Text] [Related]
28. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis]. Górska A, Urban M, Konstantynowicz J, Bartnicka M, Chlabicz S, Górski S, Kaczmarski M. Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288 [Abstract] [Full Text] [Related]
30. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW. Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443 [Abstract] [Full Text] [Related]
31. Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. Sandborg C, Holmes TH, Lee T, Biederman K, Bloch DA, Emery H, McCurdy D, Mellins ED. J Rheumatol; 2006 Nov; 33(11):2322-9. PubMed ID: 16960920 [Abstract] [Full Text] [Related]
33. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, Pederzoli S, Davì S, Martini A, Ravelli A, Paediatric Rheumatology International Trials Organization. Arthritis Rheum; 2012 Jul; 64(7):2366-74. PubMed ID: 22231288 [Abstract] [Full Text] [Related]
34. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, Cabral DA, Feldman BM, Tse S, Chédeville G, Spiegel L, Schneider R, Lang B, Ellsworth J, Ramsey S, Dancey P, Silverman E, Chetaille AL, Cameron B, Johnson N, Dorval J, Petty RE, Duffy KW, Boire G, Haddad E, Houghton K, Saint-Cyr C, Turvey SE, Benseler S, Cheang M, Yeung RS, Duffy CM. Arthritis Rheum; 2009 Aug 15; 61(8):1077-86. PubMed ID: 19644903 [Abstract] [Full Text] [Related]
38. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Clegg DO, Reda DJ, Abdellatif M. Arthritis Rheum; 1999 Nov 15; 42(11):2325-9. PubMed ID: 10555027 [Abstract] [Full Text] [Related]
39. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, Schmeling H, German and Austrian Paediatric Rheumatology Collaborative Study Group. Ann Rheum Dis; 2009 Apr 15; 68(4):519-25. PubMed ID: 18413440 [Abstract] [Full Text] [Related]
40. Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis. Graham TB, Laor T, Dardzinski BJ. J Rheumatol; 2005 Sep 15; 32(9):1811-20. PubMed ID: 16142882 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]